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Abstract
Rationale: Researchers tend to study Latinos as a single group but recent asthma research 
confirmed differences among Latino subgroups. Variations in controller medication adherence 
may be a factor in the observed health disparities between Mexican and Puerto Rican children. 
Adherence is not a stable phenomenon, however, there is a paucity of data on patterns of 
adherence, sociodemographic predictors of patterns, and variations in asthma-related acute 
healthcare utilization by adherence pattern among Latino sub-groups. 
Objectives: Identify patterns of inhaled corticosteroid medication adherence over twelve 
months among Mexican and Puerto Rican children with persistent asthma; examine socio-
demographic predictors of adherence patterns by ethnicity; and investigate asthma-related 
acute healthcare utilization based on these patterns.
Methods: We analyzed controller medication Doser data from Mexican and Puerto Rican 
children (n=123; ages 5-12 years) with persistent asthma who participated with their caregivers 
in a longitudinal, non-intervention study (Phoenix, AZ and Bronx, NY). Interview and medical 
record data were collected at enrollment, 3, 6, 9, and 12 months post-enrollment. 
Results: 47%-53% of children had poor adherence (<50%) over each of the follow-up periods 
(cross-sectional). Children with lowest adherence were Puerto Rican, from non-poor families, or 
female. Longitudinal latent class analysis yielded 4 adherence classes: poor; moderate; 
declining adherence; and increasing adherence. Puerto Rican children had significantly higher 
odds of “Decreasing” (OR=2.86; 95% CI, 0.40 to 20.50) and “Poor” (OR=5.62; 95% CI, 1.44 to 
21.90) adherence compared to Mexican children. Females had significantly greater odds of 
“Decreasing” (OR=4.80; 95% CI, 0.73 to 31.74) and “Poor” (OR=5.20; 95% CI, 1.77 to 15.30) 
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adherence group membership compared to Males. The “Decreasing” adherence group was 
comprised of only poor children. Children in the “Poor” adherence class had the highest mean 
number of acute visits and ED visits/hospitalizations across all assessment periods.
Conclusions: This study demonstrated that unique ethnicity within Latino populations may be 
associated with different risk levels for suboptimal controller medication adherence which may 
be a factor in the observed asthma health disparities between Mexican and Puerto Rican 
children. Increased understanding of and attention to children’s controller medication 
adherence patterns will provide evidence needed to identify children at highest risk for acute 
healthcare utilization and offer more intensive intervention using less-intensive approaches for 
those at low risk.
Abstract Word Count: 350
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Despite evidence-based guidelines for asthma management and control (1), low asthma 
controller medication adherence in children persists, with minority children at greater risk of 
non-adherence and poor outcomes than non-minority children (2-6). Adherence to controller 
medications is critical and can significantly reduce exacerbations and improve asthma control 
(2, 7, 8). Researchers have tended to study Latinos as a single group but recent descriptive 
asthma research has confirmed significant heterogeneity among Latino subgroups (particularly 
between Mexicans and Puerto Ricans) regarding prevalence, mortality and morbidity, illness 
beliefs, and asthma healthcare practices (9-13). Puerto Rican children exhibit the highest rates 
of asthma prevalence and mortality among all ethnic groups while Mexican children have the 
lowest rates (9, 12). Genetic, environmental, healthcare system, and provider factors (13-15) 
cannot totally explain the differences between these two groups. 
There is growing evidence about factors leading to non-adherence and interventions 
focused on improving adherence. Although an evidence-based cut-off value for good adherence 
(16) has not been established, rates >80% are traditionally considered acceptable (16, 17). The 
majority of adherence interventions primarily target children with controller medication 
adherence <80% assuming that children >80% at initial assessment will remain adherent. There 
is evidence that adherence is not a stable phenomenon (17-20), although there is a paucity of 
data on patterns of adherence among individuals with asthma and none within sub-groups of 
Latino children (21). Souverein et al. (17) examined longitudinal patterns of inhaled 
corticosteroid (ICS) medication initiation (21) among a sample of long term care patients 
(n=13,922). The results identified periods of non-adherence alternating with periods of regular 
ICS use. LaForest et al. (20) examined ICS adherence over 12 months among children and adults 
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selectively recruited for high initial adherence. The investigators noted fragmented episodes of 
ICS use which typically lasted several months even though all individuals were adherent at 
baseline (20). A better understanding of controller medication adherence patterns in children 
will provide evidence needed to identify individuals at highest risk for non-adherence and acute 
healthcare utilization and offer a more intensive intervention while using less-intensive 
approaches for those at low risk preventing waste of precious healthcare resources. 
A literature review revealed no studies directly examining controller medication 
adherence between Mexican and Puerto Rican children; thus these analyses fill a critical gap in 
our knowledge and offer insights to factors leading to asthma health disparities between these 
Latino sub-groups. The objectives of these secondary analyses were to: 1) identify patterns of 
children’s ICS medication adherence over a 12 month assessment period in a sample of 
Mexican and Puerto Rican children with persistent asthma; 2) examine sociodemographic and 
seasonal predictors of adherence patterns and; 3) investigate asthma-related acute healthcare 
utilization based on these patterns. To the best of our knowledge, this was the first study to 
examine objectively measured longitudinal patterns of ICS medication adherence in children, 
explore heterogeneity in adherence patterns within a sample of Latino children, and link those 
patterns to clinical outcomes. 
Methods
We analyzed ICS medication data from a sample of Mexican and Puerto Rican children with 
persistent asthma requiring daily controller medications (ages 5-12 years) who participated 
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with their caregivers in a longitudinal, non-intervention study (Phoenix, AZ and Bronx, NY). The 
main study tested an explanatory, integrated multi-factorial model investigating the interaction 
of individual characteristics, cultural and experiential and healthcare system factors, and social-
environmental context that lead to disparities between these two Latino sub-groups. Children 
and caregivers were recruited from two school-based health clinics and the Breathmobile in 
Phoenix, Arizona and two inner-city hospital asthma clinics in Bronx, New York. A total of 267 
child/caregiver dyads were enrolled in the main study. Structured interviews were administered 
to caregivers and shorter interviews and spirometry assessments conducted with children at 
enrollment and 3, 6, 9, and 12 months post-enrollment. A retrospective review of children’s 
medical records was completed. Objective measures of children’s ICS medication adherence 
were assessed by Doser devices (MediTrack Products, Hudson, MA) attached to the top of the 
ICS canister at baseline. Data were downloaded at each follow-up visit yielding 12 months of 
adherence measures. Due to differences in treatment regimen adherence between inhaled and 
oral and combination ICS/LABA controller medications, all children with use of oral and/or 
combination ICS/LABA  medications were excluded (n=73) from these analyses. Two children 
had no record of controller or quick relief medication prescriptions. We had Doser data on a 
subsample of 123 of 192 children (64.1%) prescribed inhaled corticosteroids. The study was 
approved by the Institutional Review Boards of the Arizona State University, Phoenix Children’s 
Hospital, Scottsdale Healthcare and Albert Einstein College of Medicine.
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Sociodemographic Characteristics
All enrolled participants self-identified as Mexican or Puerto Rican. We obtained child’s sex, 
age, and asthma duration (number of months since diagnosis); family perception of poverty; 
caregiver’s marital status and education; and season of interview. Due to the socio-legal climate 
in Phoenix, we did not ask for annual income demonstrating sensitivity to the challenges these 
families were facing. To assess caregivers’ perception of poverty, a measure adapted by Gore et 
al. (22) asked “What best describes your family’s standard of living?” Response choices ranged 
from 1=Very well off to 6=Poor and was dichotomized as Poor=Nearly Poor or Poor. All enrolled 
children/caregiver dyads were Medicaid/Medicaid-eligible and received their asthma 
medications free from the participating clinics.
Seasonality
Using each interview date, we created the season that baseline and follow-up interviews were 
conducted, adherence data captured, and acute asthma-related healthcare utilization occurred. 
Seasons were defined as: Spring=March-May; Summer=June-August; Fall=September-
November; Winter=December-February. 
Clinician-rated Asthma Severity
Clinician ratings of children’s asthma severity were conducted per clinical guidelines (1). The 
ratings were based on clinicians’ assessment of impairment given the caregivers’ and children’s 
responses to structured questions regarding daytime and nocturnal symptoms, activity 
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limitations, short-acting β2 agonist use for the 2-4 week period prior to the interview, 
spirometry, and risk of adverse events. All ratings were completed by pediatric pulmonologists.
Adherence
Doser devices were attached to the child’s ICS canister at the baseline visit. Doser data were 
downloaded at each assessment period (M3=baseline-month 3; M6=month 3-month 6; 
M9=month 6-month 9, and M12=month 9-month 12) yielding 12 months of adherence data. 
The Doser devices recorded the number of actuations each day for the prior 30 days. For 
medications where we could not attach the Doser due to built-in counters, we captured the 
counter data at each visit. Adherence data were cleaned per procedures outlined by McQuaid, 
Kopel, Klein & Fritz (23). Adherence was calculated as the # doses taken per day/# prescribed 
doses per day x 100. Daily adherence was truncated to 100% to account for accidental 
actuations (e.g., bumping in a backpack) or intentional actuations due to trying to make up for 
missed doses the previous day. Average adherence and adherence categories were created 
(<50%=Poor, 50-80%=Moderate, >80%=Good) at each time period (24). 
Acute Healthcare Utilization
Children’s medical records from the recruitment site were reviewed for 12 months prior to 
enrollment and the 12 month study period to obtain counts of acute and ED asthma visits and 
hospitalizations. Asthma-related ED visits and hospitalizations were combined due to the low 
frequency. Because asthma-related healthcare visits may have occurred outside the child’s 
medical home, caregiver reports were checked against the medical record based on visit date 
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(+/- one month to account for recall errors). In cases where the medical record and caregiver 
dates were congruent, medical record data were used. Where there was a caregiver report but 
no medical record visit for that date, caregiver report was used. If a visit was recorded in the 
medical record but not reported by the caregiver, medical record data were used.
Statistical Analyses
Only data for children prescribed an ICS medication and who had at least 2 adherence data 
points were analyzed. Cross-sectional descriptive chi-square analyses examined adherence by 
ethnicity, child sex and age, poverty, and season. Structural equation modeling and longitudinal 
latent class analysis (LLCA) explored patterns of adherence over time and acute healthcare 
utilization by adherence class. The LLCA also examined sociodemographic characteristics 
(ethnicity, marital status, poverty, caregiver education, child’s age, sex, and asthma duration, 
and number of family members with asthma) to identify predictors of class membership. 
Interaction effects for ethnicity with caregiver marital status, education, poverty, and child sex 
were examined. Reference groups were Puerto Rican, female, non-poor, summer, and 
“Moderate” adherence group. Model selection was based on the log likelihood, Bayesian 
Information Criteria (BIC), and entropy. Models specifying 2, 3, and 4 classes were run and fit 
statistics compared to determine the best fitting model (25, 26). Statistical significance was set 
at p<.10, the convention for structural equation modeling and LLCA.
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Results
A total of 267 child/caregiver dyads enrolled and completed baseline measures and 
assessments. We had adherence data for 123/192 children prescribed non-combination ICS 
medications (64.1%). Analyses were conducted (data not shown) to examine whether children 
who were missing adherence data were different from those who had adherence data based on 
ethnicity; recruitment site; number of family members with asthma; caregivers’ marital status, 
education, perception of poverty, reported use of controller medication in the past month, age 
and sex; and child’s sex, age, asthma duration and severity. Children who were missing 
adherence data were more likely to not have used controller medications in the past month, 
had mild or severe persistent asthma, and had caregivers who were older and high school 
graduates. There were no differences by ethnicity.
Table 1 presents the sample characteristics by ethnic group. Puerto Rican caregivers 
were less likely to be married or poor and more likely to have graduated from high school. 
Puerto Rican children were younger, had higher clinician ratings of severe persistent asthma, 
and lower likelihood of caregiver-reported controller medication use in the past month 
compared to Mexican children. 
Cross-sectional Analyses
Figure 1 illustrates cross-sectional adherence by time. Good adherence (>80%) at each time 
period was low (14%-23%) with the largest proportion of children demonstrating poor 
adherence (47%-53%). Puerto Rican children had the highest proportion of poor adherence at 
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each time period (63%-80%) compared to Mexican children (40%-49%)(see Figure E1A in the 
Online Supplement). Although a higher proportion of Mexican (19%-23%) compared to Puerto 
Rican children (0%-21%) had good adherence, overall, these proportions are quite low. Because 
all of the Puerto Rican children were enrolled at the Bronx hospital clinics, we conducted 
additional analyses to investigate whether adherence differences were due to ethnicity or clinic 
setting. A sub-group analysis was conducted comparing adherence for Mexican and Puerto 
Rican children enrolled at the Bronx hospital clinic sites. More Puerto Rican children in the 
hospital clinics had poor adherence at every time period (71%-80%) compared to Mexican 
children from the same clinic (33%-63%). Additionally, we examined adherence by site to 
determine whether adherence was lowest at the hospital-based clinics in the Bronx compared 
to the other sites. The school-based health centers in Phoenix actually had the lowest 
adherence across all assessment periods (range 10%-31%) followed by the hospital-based 
clinics (range 34%-38%) with the Breathmobile consistently having the highest adherence 
(range 50%-56%). These findings support our conclusion of ethnic differences unrelated to clinic 
site. Good adherence was low for both sexes ranging from 5% to 23% (see Figure E1B in the 
Online Supplement). Across all time periods, females demonstrated the highest proportions of 
poor adherence (55%-77%). At M3 and M6, more non-poor children demonstrated poor 
adherence compared to poor children. These differences dissipated over time (see Figure E2A 
in the Online Supplement). There were no seasonal differences in adherence at any time period 
(see Figure E2B in the Online Supplement). Similar adherence proportions were observed for 
younger and older children with the majority having poor adherence across all time periods 
(data not shown). 
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Longitudinal Latent Class Analysis
We tested 2, 3 and 4 class models examining adherence patterns from baseline through 12 
months. Multiple imputation was used to impute missing data for the 123 children that had 
adherence data for at least 2 time periods. The LLCA revealed that the four class solution was 
the best of the three models tested. These classes of adherence are: poor (47%); moderate 
(31%); declining adherence (good or moderate adherence transitioning to poor adherence) 
(7%); and increasing adherence (poor adherence shifting to moderate or good adherence) 
(15%) (Figure 2). Table 2 presents the results for significant predictors of adherence class 
membership; ethnicity, child sex, and poverty. No differences were observed for marital status, 
caregiver’s education, child’s age, asthma duration, or number of family members with asthma. 
Puerto Rican children had significantly higher odds of being in the “Decreasing” and “Poor” 
adherence groups compared to Mexican children. Females had significantly greater odds of 
being in the “Decreasing” and “Poor” adherence groups compared to Males; no females were 
in the “Improving” adherence class. The “Decreasing” adherence class was comprised of only 
poor children and these children also had lower odds of being in the “Improving” adherence 
class. No interaction effects of ethnicity with caregiver marital status, education, poverty, or 
child sex were observed (data not shown).
Differences in asthma-related healthcare utilization (i.e., acute care visits and ED 
visits/hospitalizations) were examined by adherence class and modeled by assessment period 
across 12 months. These results are presented as forest plots (Figures 3 and 4, respectively) 
where the x-axis represents the mean difference and I2 is a measure of heterogeneity between 
the groups. For these analyses, I2 >50% is considered statistically significant. Because of small 
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class sizes and low frequency of healthcare visits, we examined effect sizes to ascertain 
clinically meaningful (effect size >=.20) differences between classes for acute care visits and ED 
visits/hospitalizations in addition to statistically significant differences. For acute visits, 
statistically significant heterogeneity was observed among the different adherence classes 
(excluding Month 9) as evidenced by I2 values ranging from 63%-78%. With the exception of 
Month 9, small to moderate clinically meaningful differences were also noted over time (effect 
sizes ranging from 0.22 to 0.55) although there was no discernable pattern to these differences. 
Figures E3A in the Online Supplement plots the mean number of acute visits at each 
assessment period by adherence class. The “Moderate” adherence class had the lowest acute 
visits through M9 but demonstrated a large increase from M9 to M12. The “Decreasing” 
adherence class initially had the highest acute visits which decreased through M9 and 
plateaued at M12. At M3, the “Increasing” adherence class had low acute visits which peaked 
at M6 and then declined through M9 and M12. With the exception of M9, the “Poor” 
adherence class had the highest acute visits.
A different pattern emerged for ED visits/hospitalizations. Statistically significant 
heterogeneity between adherence classes was observed only at Month 6 and Month 9 (I2=80% 
and 73%, respectively). However, only the difference between the poor and moderate 
adherence classes was clinically meaningful (effect size=.23). At M3, all four classes had 
equivalent ED visits/hospitalizations. At M6, the “Poor” adherence class had significantly 
greater ED visits/hospitalizations compared to the remaining classes, a finding which held 
across M9 and M12 (Figure E3B in the Online Supplement). The “Moderate” adherence class 
had the lowest ED visits/hospitalizations at M6 but demonstrated steadily increasing visits 
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through M9 and M12. The “Increasing” adherence class exhibited steady declines in ED 
visits/hospitalizations from baseline through M9 which then dramatically increased at M12. The 
“Decreasing” adherence class had relatively stable ED visits/hospitalizations across the 12 
month assessment period. Examination of the between class differences revealed clinically 
meaningful differences for almost all contrasts (excluding M6 increasing vs. decreasing 
adherence and M12 increasing vs. poor adherence) from M3 through M12 months.   
Discussion
These results add to our emerging evidence on patterns of ICS medication adherence in 
children. Notably, in our cross-sectional analyses, few children had adherence rates consistently 
>80% and less than one third were classified as having moderate adherence (50%-80%). Our 
LLCA identified four classes of adherence with the majority (78%) classified as poor or 
moderate. This finding supports the tendency to focus interventions on individuals with 
adherence <80% using a risk/benefit approach. These results revealed that acute healthcare 
utilization differed by adherence class over time. Children in the “Poor” adherence class had the 
highest utilization across the entire 12 month period but there was an unexplained drop in 
acute visits between M6 and M9 which was not explained by season. The “Decreasing” 
adherence group had steadily declining acute visits and relatively stable ED 
visits/hospitalizations over the 12 month assessment period which may be due to caregivers 
stepping down therapy or stopping therapy when the child has been asymptomatic for a period 
of time. Several studies have reported that caregivers have a strong desire for their children to 
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be medication-free and thus, discontinue using controller medications when the child no longer 
“has asthma” (27, 28).  As we anticipated, children in the “Moderate” adherence group also had 
the lowest number of acute visits through M9. An unexpected finding was a dramatic increase 
in acute visits between M9 and M12, similar to what we observed for the poor adherence class. 
Again, this was not due to seasonal effects. When the “Improving” adherence class emerged, 
given that this was not an intervention study, we hypothesized that possibly an ED visit or 
hospitalization was the “trigger” for getting back on track with the prescribed regimen and this 
group of caregivers intervened early enough to prevent ED visits and hospitalizations. There is 
some support for this as evidenced by declining acute visits from M3 through M12 and slightly 
declining ED visits/hospitalizations through M9. However, this group had a substantial increase 
in ED visits/hospitalizations from M9 to M12 months almost equaling the poor adherence class. 
Once more, this increase was not associated with season. 
It is worth noting that evidence from prior research suggests that adherence in Latino 
children is strongly affected by children’s and caregiver’s symptom perception which is not 
highly accurate (29-31) and differs between Puerto Rican and other Latino sub-groups (32, 33); 
cultural beliefs about asthma and medication use (27, 28); and other socio-economic factors. 
This suggests close clinical monitoring of ICS medication use and development of targeted 
interventions to address inaccurate symptom perception and sub-optimal treatment patterns in 
this at-risk population. Given that pediatric adherence is heavily influenced by parental 
involvement, effective intervention may require tailoring to specific cultural needs at both adult 
(parent, grandparent) and child level. 
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Our study also is the first study showing that unique ethnic identity within Latino 
populations may be associated with different risk levels and highlights the role of 
socioeconomic factors. We demonstrated that Puerto Rican children were at substantially 
greater risk of poor adherence compared to Mexican children and that poor adherence led to 
the highest acute healthcare utilization across time. This supports our notion that adherence 
patterns may be a factor in Latino children’s asthma health disparities. Our findings are 
pertinent in addressing the differences in asthma burden between Mexican and Puerto Rican 
children. Puerto Rican children, on average, were half as adherent as Mexican children. Lack of 
adherence to ICS medications in our study highlights the role of these medications in the lack of 
bronchodilator responsiveness observed to a higher extent among Puerto Rican compared to 
Mexican children (36). It is unsurprising that poverty adversely affects adherence. Lack of 
adherence to medications in poor families is likely multifactorial. For many of these families 
lacking sufficient resources, purchasing controller medications may be a lower priority when 
there are competing demands for limited resources. Although Puerto Ricans perceived 
themselves as less poor than Mexicans and all study children received their ICS medications for 
free, they had lower adherence suggesting that factors other than poverty contributed to their 
lack of adherence. Higher asthma burden has been reported among female children compared 
to male (4, 37) and our findings confirm that with females exhibiting greater odds of decreasing 
and poor adherence. One explanation may be that as girls get older there is social pressure to 
look and act a certain way and using an inhaler may make them feel “different.” 
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Limitations
There are several important limitations. Objective measures of adherence were based on Doser 
tracking devices attached to the child’s ICS canister. The devices we used were capable of only 
storing the most recent 30 days of usage. Thus, we were unable to examine adherence 
continuously across the 12 month assessment period. Only 64% of the children had valid 
adherence data, thus, poor medication adherence may actually be under-estimated because 
this sub-sample may represent those individuals who were reliable enough to bring the 
medications to the visits. Additionally, several of the class sizes were small and thus, we may 
not have had adequate statistical power to assess longitudinal between adherence class 
differences. Lastly, we did not have pharmacy fill/refill data to compute the medication 
possession ratio or controller to total medication ratio as additional measures of adherence.
Implications and Future Research
Our findings suggest medication adherence is a major contributor to disease burden and acute 
healthcare utilization among urban Latino children. To the best of our knowledge, this was the 
first study which characterized longitudinal patterns of children’s asthma ICS medication 
adherence and demonstrated differing risk levels for non-adherence based on ethnicity within 
the Latino population. Future research should further explore these patterns and risk factors 
among more heterogeneous Latino samples to inform targeted adherence intervention 
strategies. Health technology and wearable sensors are transforming our ability to monitor 
adherence beyond simply counting device actuations to assessing inhaler technique and 
capturing clinically meaningful data such as exhaled nitrous oxide, cough rate, and respiration 
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patterns which can seamlessly upload data through wireless connectivity and Smartphone apps 
(38). Given that a significant proportion of children did not have adherence data and our Dosers 
could not continuously monitor adherence, future studies should incorporate these monitoring 
devices to more precisely examine the intra- and inter-person variability longitudinally and 
minimize missing adherence data. This technology could support adherence interventions that 
can be tailored to different ethnic sub-groups.
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Table 1. Sample Baseline Characteristics (n=123)
Variable Mexican 
(N=89)
Puerto 
Rican 
(N=34)
N (%) N (%)
Recruitment Site
Hospital Clinic (NY) 17 (19.10) 34 (100)
Breathmobile (AZ) 61 (68.54) 0
School-based Health Center (AZ) 11 (12.36) 0
Season of Baseline Interview
Summer 25 (28.09) 8 (23.53)
Fall 21 (23.60) 12 (35.29)
Winter 26 (29.21) 8 (23.53)
Spring 17 (19.10) 6 (17.65)
Child: N (%) N (%)
Child Sex (% Female) 31 (34.8) 15 (44.1)
Clinician-rated Asthma Severity
Mild intermittent 9 (10.34) 3 (9.68)
Mild persistent 27 (31.03) 5 (16.13)
Moderate persistent 47 (54.02) 18 (58.06)
Severe persistent 4 (4.06) 5 (16.13)
Any Controller Medication Use in the Past Month (% Yes) 78 (87.64) 27 (79.41)
Mean (SD) Mean (SD)
Study Child’s Age (Years) 9.53 (2.14) 8.64 (1.97)
Asthma Duration (# months since diagnosis) 68.28 
(36.22)
82.21 
(33.21)
% Adherent: Month 3 47.51 
(30.05)
35.65 
(28.91)
% Adherent: Month 6 53.47 
(31.47)
35.44 
(37.86)
% Adherent: Month 9 51.27 
(28.68)
29.94 
(27.57)
% Adherent: Month 12 53.09 
(29.39)
26.41 
(29.29)
Caregiver N (%) N (%)
Married (% Yes) 45 (50.56) 9 (26.47)
Poor (% Yes) 59 (66.29) 10 (29.41)
High School Graduate (% Yes) 34 (38.20) 19 (55.88)
Caregiver Sex (% Female) 85 (95.51) 32 (94.12)
Mean (SD) Mean (SD)
Caregiver’s Age 34.57 
(6.41)
36.00 (9.39)
# Family Members w/Asthma 1.17 (0.73) 0.82 (1.11)
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Table 2. Sociodemographic Predictors of Controller Medication Adherence Class Membership
Variable Model 
χ2
OR (95% CI)
Ethnicity 9.15
   Improving Adherence
Mexican
Puerto Rican
Referent
.73 (.05, 11.86)
    Decreasing Adherence
Mexican
Puerto Rican
Referent
2.86 (.40, 20.50)
   Poor Adherence
Mexican
Puerto Rican
Referent
5.62 (1.44, 21.90)
Child Sex 85.07
   Improving Adherence
Male
Female
Referent
0 
   Decreasing Adherence
Male
Female
Referent
4.80 (.73, 31.74)
   Poor Adherence
Male
Female
Referent
5.20 (1.77, 15.30)
Poverty 99.49
   Improving Adherence
Non-Poor
Poor
Referent
.41 (.07, 2.34)
   Decreasing Adherence
Non-Poor
Poor
Referent
0
   Poor Adherence
Non-Poor
Poor
Referent
.74 (.25, 2.13)
*Moderate adherence is the referent group
Definition of abbreviations: CI=confidence interval; OR=odds ratio
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Figure Legends:
Figure 1. Categorical Cross-Sectional Adherence
Figure 2. Longitudinal Latent Class Analysis: 4 Class Solution
Figure 3. Forest Plot of Longitudinal Acute Healthcare Visits by Adherence Class
Figure 4. Forest Plot of Longitudinal ED Visits/Hospitalizations by Adherence Class
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Heterogeneity between groups: p = 0.000
I-V Overall  (I-squared = 73.2%, p = 0.000)
I-V Subtotal  (I-squared = 63.4%, p = 0.018)
Moderate vs. Increasing
Decreasing vs. Moderate
Poor vs. Increasing
Month 12
Decreasing vs. Moderate
ID
I-V Subtotal  (I-squared = 74.6%, p = 0.001)
Decreasing vs. Increasing
Moderate vs. Increasing
Poor vs. Decreasing
Study
Poor vs. Moderate
Poor vs. Moderate
Decreasing vs. Moderate
Moderate vs. Increasing
Poor vs. Moderate
Month 9
D+L Overall
Poor vs. Increasing
Poor vs. Increasing
Poor vs. Decreasing
Decreasing vs. Increasing
Decreasing vs. Increasing
Poor vs. Moderate
Month 6
Poor vs. Increasing
Month 3
Poor vs. Decreasing
Decreasing vs. Increasing
Poor vs. Decreasing
I-V Subtotal  (I-squared = 45.2%, p = 0.104)
Moderate vs. Increasing
Decreasing vs. Moderate
I-V Subtotal  (I-squared = 77.5%, p = 0.000)
0.12 (0.10, 0.14)
0.16 (0.11, 0.21)
0.11 (0.06, 0.16)
0.03 (-0.03, 0.09)
0.23 (0.11, 0.35)
0.30 (0.22, 0.38)
0.13 (0.09, 0.18)
0.04 (-0.05, 0.13)
0.08 (0.02, 0.14)
0.45 (-0.11, 1.01)
0.01 (-0.09, 0.11)
0.23 (0.14, 0.32)
0.10 (0.02, 0.18)
0.19 (0.11, 0.27)
0.09 (0.03, 0.15)
0.14 (0.10, 0.18)
0.02 (-0.06, 0.10)
0.15 (0.02, 0.28)
0.27 (0.10, 0.44)
0.22 (0.12, 0.32)
0.14 (0.05, 0.23)
0.55 (0.28, 0.82)
0.36 (-0.03, 0.75)
0.01 (0.01, 0.23)
0.09 (-0.05, 0.23)
0.07 (-0.12, 0.25)
0.07 (0.05, 0.10)
0.22 (0.11, 0.33)
0.26 (0.11, 0.41)
0.17 (0.13, 0.21)
100.00
13.41
11.96
10.02
2.34
5.12
(I-V)
15.41
3.95
10.02
0.11
Weight
3.56
4.21
5.00
5.73
11.12
%
5.19
2.05
1.22
3.22
4.31
0.48
0.22
2.94
1.86
1.02
45.53
2.83
1.51
25.65
ES (95% CI)
-1.01 
Decreased Acute Care Utilization   Mean Difference
1.01
Increased Acute Care Utilization
0
I2=heterogeneity between the groups; >=50% indicates statistically significant differences
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Heterogeneity between groups: p = 0.000
I-V Overall  (I-squared = 66.5%, p = 0.000)
Poor vs. Moderate
I-V Subtotal  (I-squared = 79.5%, p = 0.000)
Moderate vs. Increasing
Moderate vs. Increasing
Poor vs. Moderate
Month 12
Decreasing vs. Increasing
Decreasing vs. Increasing
Decreasing vs. Moderate
Decreasing vs. Increasing
Moderate vs. Increasing
I-V Subtotal  (I-squared = 0.0%, p = 0.933)
Poor vs. Decreasing
Poor vs. Increasing
D+L Overall
ID
Poor vs. Decreasing
I-V Subtotal  (I-squared = 72.5%, p = 0.003)
Poor vs. Increasing
Decreasing vs. Increasing
Poor vs. Moderate
Decreasing vs. Moderate
Study
Month 9
Month 6
Moderate vs. Increasing
Decreasing vs. Moderate
Decreasing vs. Moderate
Poor vs. Increasing
Poor vs. Increasing
Poor vs. Decreasing
Poor vs. Moderate
Poor vs. Decreasing
Month 3
I-V Subtotal  (I-squared = 0.0%, p = 0.996)
0.09 (0.07, 0.10)
0.23 (0.17, 0.29)
0.11 (0.09, 0.13)
0.03 (-0.01, 0.07)
0.10 (0.07, 0.13)
0.17 (0.12, 0.22)
0.08 (-0.01, 0.17)
0.02 (-0.09, 0.13)
0.04 (-0.03, 0.11)
0.08 (-0.01, 0.17)
0.04 (-0.02, 0.10)
0.05 (0.02, 0.08)
0.10 (-0.06, 0.26)
0.02 (-0.09, 0.13)
0.08 (0.05, 0.10)
ES (95% CI)
0.12 (-0.00, 0.24)
0.09 (0.07, 0.12)
0.14 (0.06, 0.22)
0.01 (-0.06, 0.08)
0.06 (-0.02, 0.14)
0.11 (0.06, 0.16)
0.04 (-0.03, 0.11)
0.02 (-0.07, 0.11)
0.11 (0.08, 0.15)
0.01 (-0.08, 0.10)
0.13 (0.04, 0.22)
0.01 (-0.11, 0.13)
0.03 (-0.03, 0.09)
0.06 (-0.05, 0.17)
0.02 (-0.01, 0.06)
100.00
4.72
44.32
8.89
19.55
5.64
2.17
1.41
3.66
1.86
4.89
15.08
0.68
%
1.29
(I-V)
1.09
26.46
2.57
3.36
2.70
5.85
Weight
3.09
2.17
13.42
2.12
2.17
1.20
4.14
1.33
14.14
Decreased ED/Hospitalization  Mean Difference Increased ED/Hospitalization 
0-.291 .291
I2=heterogeneity between groups; >=50% indicates statistically significant differences
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Online Data Supplement
Longitudinal Patterns of Mexican and Puerto Rican Children’s Asthma Controller Medication 
Adherence and Acute Healthcare Utilization
Kimberly J. Arcoleo, PhD, MPH, Colleen McGovern, PhD, MPH, RN, Karenjot Kaur, BA, Jill S. 
Halterman, MD, MPH, Jennifer Mammen, PhD, NP-C, Hugh Crean, PhD, Deepa Rastogi, MBBS, 
MS, Jonathan M. Feldman, PhD
Supplemental Figure Legend
Figure E1A. Categorical Cross-Sectional Adherence by Ethnicity
Figure E1B. Categorical Cross-Sectional Adherence by Child Sex
Figure E2A. Categorical Cross-Sectional Adherence by Poverty Status
Figure E2B. Categorical Cross-Sectional Adherence by Season
Figure E3A. Longitudinal Latent Class Analysis for Acute Visits by Adherence Class
Figure E3B. Longitudinal Latent Class Analysis for ED Visits/Hospitalizations by Adherence 
Class
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 Figure E3A. Longitudinal Latent Class Analysis for Acute Visits by Adherence Class 
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 Figure E3B. Longitudinal Latent Class Analysis for ED Visits/Hospitalizations by Adherence Class 
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